Summit Therapeutics at #ASCO2026 (Karen Weintraub for Endpoints News) June 11, 2026 11:12 AM EDT Financing Summit withdraws $500M offering, citing 'market conditions' Max Gelman Senior Editor The current biotech environment can apparently support an industry-record IPO and simultaneously hamper efforts to raise half a billion dollars. Summit Therapeutics ditched plans for … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
endpoints· 1mo ago
saveSummit withdraws $500M offering, citing 'market conditions'
June 11, 2026read original ↗
The current biotech environment can apparently support an industry-record IPO and simultaneously hamper efforts to raise half a billion dollars.
87 words · extracted 1mo agoread original ↗
🔗 mentioned in this article
no entities indexed yet
comments(0)
5-min edit window · permanent after that